Skip to search formSkip to main contentSkip to account menu

DMP 754

Known as: DMP-754, DMP754 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

roxifiban acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease
Introduction: Intravenous platelet glycoprotein (GP) IIb/IIIa receptor inhibitors have a significant beneficial impact on the… 
1999
1999
Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459.
Currently used antiplatelet drugs, including aspirin, ticlopidine, and others, are effective against certain but not all of the… 
1999
1999
Disposition and exposure of the fibrinogen receptor antagonist XV459 on alphaIIBbeta3 binding sites in the guinea pig.
The disposition of XV459, a potent, selective GP IIb/IIIa antagonist, has been examined following intravenous administration of… 
1998
1998
Oral antiplatelet efficacy of the platelet GPIIb/IIIa antagonist, DMP754 in non-human primates.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)